Literature DB >> 25712921

Regarding Ening et al. Charlson comorbidity index: an additional prognostic parameter for preoperative glioblastoma patient stratification.

Alba Fiorentino1, Francesco Ricchetti, Rosario Mazzola, Sergio Fersino, Niccolò Giaj Levra, Filippo Alongi.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25712921     DOI： 10.1007/s00432-015-1944-z

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN： 0171-5216            Impact factor:   4.553


× No keyword cloud information.
  7 in total

1.  Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer.

Authors:  Ozcan Birim; A Pieter Kappetein; Ad J J C Bogers
Journal:  Eur J Cardiothorac Surg       Date:  2005-09-12       Impact factor: 4.191

Review 2.  Elderly patients with glioblastoma: the treatment challenge.

Authors:  Alba Fiorentino; Pasquale De Bonis; Silvia Chiesa; Mario Balducci; Vincenzo Fusco
Journal:  Expert Rev Neurother       Date:  2013-10       Impact factor: 4.618

3.  Comorbidities and Charlson score in resected stage I nonsmall cell lung cancer.

Authors:  D Moro-Sibilot; A Aubert; S Diab; S Lantuejoul; P Fourneret; E Brambilla; C Brambilla; P Y Brichon
Journal:  Eur Respir J       Date:  2005-09       Impact factor: 16.671

4.  Charlson comorbidity index: an additional prognostic parameter for preoperative glioblastoma patient stratification.

Authors:  G Ening; F Osterheld; D Capper; K Schmieder; C Brenke
Journal:  J Cancer Res Clin Oncol       Date:  2015-01-11       Impact factor: 4.553

5.  Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional phase II studies.

Authors:  Mario Balducci; Alba Fiorentino; Pasquale De Bonis; Silvia Chiesa; Stefania Manfrida; Giuseppe Roberto D'Agostino; Giovanna Mantini; Vincenzo Frascino; Gian Carlo Mattiucci; Berardino De Bari; Annunziato Mangiola; Francesco Miccichè; Maria Antonietta Gambacorta; Gabriella Colicchio; Alessio Giuseppe Morganti; Carmelo Anile; Vincenzo Valentini
Journal:  Med Oncol       Date:  2012-06-07       Impact factor: 3.064

6.  An open multicenter phase II trial of docetaxel-gemcitabine in Charlson score and performance status (PS) selected elderly patients with stage IIIB pleura/IV non-small-cell lung cancer (NSCLC): the GFPC 02-02a study.

Authors:  H LeCaer; P Fournel; H Jullian; C Chouaid; J Letreut; P Thomas; D Paillotin; M Perol; C Gimenez; A Vergnenegre
Journal:  Crit Rev Oncol Hematol       Date:  2007-07-31       Impact factor: 6.312

7.  Comorbidity assessment and adjuvant radiochemotherapy in elderly affected by glioblastoma.

Authors:  Alba Fiorentino; Rocchina Caivano; Costanza Chiumento; Mariella Cozzolino; Stefania Clemente; Piernicola Pedicini; Vincenzo Fusco
Journal:  Med Oncol       Date:  2012-05-12       Impact factor: 3.064
  7 in total
  2 in total

1.  Surgery of Motor Eloquent Glioblastoma Guided by TMS-Informed Tractography: Driving Resection Completeness Towards Prolonged Survival.

Authors:  Carolin Weiss Lucas; Andrea Maria Faymonville; Ricardo Loução; Catharina Schroeter; Charlotte Nettekoven; Ana-Maria Oros-Peusquens; Karl Josef Langen; N Jon Shah; Gabriele Stoffels; Volker Neuschmelting; Tobias Blau; Hannah Neuschmelting; Martin Hellmich; Martin Kocher; Christian Grefkes; Roland Goldbrunner
Journal:  Front Oncol       Date:  2022-05-27       Impact factor: 5.738

2.  Whole brain radiotherapy with hippocampal avoidance and simultaneous integrated boost for brain metastases: a dosimetric volumetric-modulated arc therapy study.

Authors:  Niccolò Giaj Levra; Gianluisa Sicignano; Alba Fiorentino; Sergio Fersino; Francesco Ricchetti; Rosario Mazzola; Stefania Naccarato; Ruggero Ruggieri; Filippo Alongi
Journal:  Radiol Med       Date:  2015-08-01       Impact factor: 3.469
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.